Nippon Chemiphar Co., Ltd. (4539.T)
JPY 1475.0
(0.68%)
JPY 1475.0
(0.68%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 10.72 Billion JPY | -0.31% |
| 2022 | 10.75 Billion JPY | 22.06% |
| 2021 | 8.81 Billion JPY | 17.5% |
| 2020 | 7.49 Billion JPY | 3.24% |
| 2019 | 7.26 Billion JPY | 14.05% |
| 2018 | 6.36 Billion JPY | 3.65% |
| 2017 | 6.14 Billion JPY | 7.81% |
| 2016 | 5.7 Billion JPY | 10.17% |
| 2015 | 5.17 Billion JPY | -2.78% |
| 2014 | 5.32 Billion JPY | -1.57% |
| 2013 | 5.4 Billion JPY | 35.41% |
| 2012 | 3.99 Billion JPY | -1.31% |
| 2011 | 4.04 Billion JPY | 39.76% |
| 2010 | 2.89 Billion JPY | -11.31% |
| 2009 | 3.26 Billion JPY | 36.17% |
| 2008 | 2.39 Billion JPY | 3.72% |
| 2007 | 2.31 Billion JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 10.94 Billion JPY | 2.07% |
| 2024 Q2 | 10.95 Billion JPY | 0.14% |
| 2023 FY | 10.72 Billion JPY | -0.31% |
| 2023 Q2 | 11.87 Billion JPY | 1.96% |
| 2023 Q4 | 10.72 Billion JPY | -7.8% |
| 2023 Q1 | 11.65 Billion JPY | 8.33% |
| 2023 Q3 | 11.62 Billion JPY | -2.1% |
| 2022 Q2 | 9.9 Billion JPY | 9.09% |
| 2022 Q1 | 9.07 Billion JPY | 3.04% |
| 2022 Q3 | 10.32 Billion JPY | 4.25% |
| 2022 FY | 10.75 Billion JPY | 22.06% |
| 2022 Q4 | 10.75 Billion JPY | 4.16% |
| 2021 Q3 | 8.59 Billion JPY | 9.18% |
| 2021 FY | 8.81 Billion JPY | 17.5% |
| 2021 Q1 | 7.43 Billion JPY | -0.91% |
| 2021 Q2 | 7.87 Billion JPY | 5.99% |
| 2021 Q4 | 8.81 Billion JPY | 2.47% |
| 2020 Q2 | 7.59 Billion JPY | 1.47% |
| 2020 Q1 | 7.48 Billion JPY | 2.97% |
| 2020 Q3 | 7.91 Billion JPY | 4.26% |
| 2020 FY | 7.49 Billion JPY | 3.24% |
| 2020 Q4 | 7.49 Billion JPY | -5.23% |
| 2019 Q1 | 6.95 Billion JPY | 9.14% |
| 2019 Q2 | 6.96 Billion JPY | 0.16% |
| 2019 FY | 7.26 Billion JPY | 14.05% |
| 2019 Q4 | 7.26 Billion JPY | -1.88% |
| 2019 Q3 | 7.4 Billion JPY | 6.33% |
| 2018 Q2 | 6.27 Billion JPY | 1.55% |
| 2018 Q3 | 6.57 Billion JPY | 4.8% |
| 2018 FY | 6.36 Billion JPY | 3.65% |
| 2018 Q4 | 6.36 Billion JPY | -3.13% |
| 2018 Q1 | 6.17 Billion JPY | 0.54% |
| 2017 Q1 | 5.96 Billion JPY | 4.61% |
| 2017 Q4 | 6.14 Billion JPY | -0.18% |
| 2017 Q3 | 6.15 Billion JPY | 10.56% |
| 2017 Q2 | 5.56 Billion JPY | -6.62% |
| 2017 FY | 6.14 Billion JPY | 7.81% |
| 2016 Q1 | 5.25 Billion JPY | 1.53% |
| 2016 Q4 | 5.7 Billion JPY | 3.43% |
| 2016 Q3 | 5.51 Billion JPY | 6.58% |
| 2016 Q2 | 5.17 Billion JPY | -1.56% |
| 2016 FY | 5.7 Billion JPY | 10.17% |
| 2015 Q3 | 5.19 Billion JPY | 8.58% |
| 2015 FY | 5.17 Billion JPY | -2.78% |
| 2015 Q4 | 5.17 Billion JPY | -0.33% |
| 2015 Q2 | 4.78 Billion JPY | -11.58% |
| 2015 Q1 | 5.4 Billion JPY | 1.6% |
| 2014 Q2 | 5.79 Billion JPY | -10.12% |
| 2014 Q4 | 5.32 Billion JPY | -2.19% |
| 2014 FY | 5.32 Billion JPY | -1.57% |
| 2014 Q3 | 5.44 Billion JPY | -6.17% |
| 2014 Q1 | 6.45 Billion JPY | 19.33% |
| 2013 Q2 | 3.97 Billion JPY | -8.89% |
| 2013 Q3 | 4.36 Billion JPY | 9.73% |
| 2013 Q4 | 5.4 Billion JPY | 23.9% |
| 2013 FY | 5.4 Billion JPY | 35.41% |
| 2013 Q1 | 4.36 Billion JPY | 9.32% |
| 2012 Q1 | 4.66 Billion JPY | 15.4% |
| 2012 Q3 | 4.07 Billion JPY | -13.64% |
| 2012 Q2 | 4.71 Billion JPY | 0.96% |
| 2012 FY | 3.99 Billion JPY | -1.31% |
| 2012 Q4 | 3.99 Billion JPY | -1.92% |
| 2011 Q1 | 3.8 Billion JPY | 31.26% |
| 2011 Q4 | 4.04 Billion JPY | 13.84% |
| 2011 FY | 4.04 Billion JPY | 39.76% |
| 2011 Q3 | 3.55 Billion JPY | -5.73% |
| 2011 Q2 | 3.77 Billion JPY | -0.79% |
| 2010 Q3 | 3.31 Billion JPY | -9.53% |
| 2010 Q4 | 2.89 Billion JPY | -12.59% |
| 2010 FY | 2.89 Billion JPY | -11.31% |
| 2010 Q1 | 3.94 Billion JPY | 20.77% |
| 2010 Q2 | 3.66 Billion JPY | -7.13% |
| 2009 Q2 | 2.54 Billion JPY | 0.0% |
| 2009 Q4 | 3.26 Billion JPY | -10.31% |
| 2009 Q3 | 3.63 Billion JPY | 43.15% |
| 2009 FY | 3.26 Billion JPY | 36.17% |
| 2008 Q3 | 2.81 Billion JPY | 0.0% |
| 2008 Q4 | 2.39 Billion JPY | -14.79% |
| 2008 FY | 2.39 Billion JPY | 3.72% |
| 2007 FY | 2.31 Billion JPY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 6.71 Billion JPY | -59.625% |
| Takeda Pharmaceutical Company Limited | 1209.86 Billion JPY | 99.114% |
| Sumitomo Pharma Co., Ltd. | 115.35 Billion JPY | 90.705% |
| Shionogi & Co., Ltd. | 64.91 Billion JPY | 83.483% |
| Wakamoto Pharmaceutical Co.,Ltd. | 2 Billion JPY | -434.487% |
| Nippon Shinyaku Co., Ltd. | 39.11 Billion JPY | 72.586% |
| Kaken Pharmaceutical Co., Ltd. | 17.16 Billion JPY | 37.543% |
| Eisai Co., Ltd. | 174.65 Billion JPY | 93.861% |
| Morishita Jintan Co., Ltd. | 3.18 Billion JPY | -236.641% |
| Hisamitsu Pharmaceutical Co., Inc. | 21.17 Billion JPY | 49.367% |
| Mochida Pharmaceutical Co., Ltd. | 30.27 Billion JPY | 64.588% |
| Fuso Pharmaceutical Industries,Ltd. | 14.2 Billion JPY | 24.504% |
| Tsumura & Co. | 117.61 Billion JPY | 90.884% |
| Kissei Pharmaceutical Co., Ltd. | 26.29 Billion JPY | 59.226% |
| Torii Pharmaceutical Co., Ltd. | 10.74 Billion JPY | 0.186% |
| Towa Pharmaceutical Co., Ltd. | 101.07 Billion JPY | 89.392% |
| Fuji Pharma Co., Ltd. | 19.37 Billion JPY | 44.649% |
| Zeria Pharmaceutical Co., Ltd. | 14.48 Billion JPY | 26.003% |
| KYORIN Holdings, Inc. | 53.47 Billion JPY | 79.948% |
| Taiko Pharmaceutical Co.,Ltd. | 1.95 Billion JPY | -449.283% |
| Daito Pharmaceutical Co.,Ltd. | 20.89 Billion JPY | 48.674% |
| SymBio Pharmaceuticals Limited | 232.03 Million JPY | -4520.954% |
| MedRx Co., Ltd | 10 Million JPY | -107120.0% |
| Mizuho Medy Co.,Ltd. | 1.59 Billion JPY | -571.549% |
| Solasia Pharma K.K. | 122 Million JPY | -8688.525% |
| Modalis Therapeutics Corporation | 6.35 Million JPY | -168670.66% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 20.4 Billion JPY | 47.446% |
| Sawai Group Holdings Co., Ltd. | 100 Billion JPY | 89.278% |
| Cyfuse Biomedical K.K. | 46.04 Million JPY | -23185.916% |
| Toho Holdings Co., Ltd. | 87.28 Billion JPY | 87.716% |
| Koa Shoji Holdings Co.,Ltd. | 2.26 Billion JPY | -373.115% |